The presentations will take place during the ACG Annual Meeting being held in
EG and/or EoD Prevalence Data Presentations:
Title (Presenter): | Endoscopy and Systematic Biopsy of Patients With Moderate-Severe Unexplained Gastrointestinal Symptoms Compared With Healthy Controls: High Discovery Rate of Eosinophilic Gastritis and/or Eosinophilic Duodenitis ( |
Session (#, Time): | Poster Session: Stomach (FP0999/S1405, |
Title (Presenter): | Patients With Eosinophilic Esophagitis and Gastrointestinal Symptoms May Have Eosinophilic Gastritis and/or Duodenitis, Not Associated With Peak Esophageal Eosinophil Count ( |
Session (#, Time): | Poster Session: Esophagus (P0306/S376, |
Lirentelimab (AK002) Presentations:
Title (Presenter): | Safety and Efficacy of Long-Term Treatment With Lirentelimab, a Monoclonal Antibody Against Siglec-8, in Patients With Eosinophilic Gastritis and/or Duodenitis ( |
Session (#, Time): | Poster Session: Stomach (P2033/S1421, |
Title (Presenter): | Similar Efficacy of Lirentelimab in Patients With New vs Prior Diagnoses of Eosinophilic Gastritis and/or Duodenitis in a Randomized Trial ( |
Session (#, Time): | Poster Session: Stomach (P2043/S1431, |
Diagnosis of EG and/or EoD Presentations:
Title (Presenter): | Systematic Collection of Biopsies and Quantification of Eosinophils in Multiple High-Power Fields is Required for Diagnosis of Eosinophilic Gastritis and/or Duodenitis ( |
Session (#, Time): | Poster Session: Stomach (P3085/S1453, |
Title (Presenter): | General Pathologists Do Not Routinely Evaluate Gastric or Duodenal Eosinophilia ( |
Session (#, Time): | Poster Session: Functional Bowel Disease (P1445/S524, |
Following the presentations, the posters and slides will be available on the
About
Source:
Investor Contact:
ir@allakos.com
Media Contact:
denise@redhousecomms.com
Source:
2021 GlobeNewswire, Inc., source